# A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)

> **NCT05084053** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Takeda** · enrollment: 26 (actual)

## Conditions studied

- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Multifocal Motor Neuropathy (MMN)

## Interventions

- **DRUG:** TAK-771

## Key facts

- **NCT ID:** NCT05084053
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-19
- **Primary completion:** 2024-03-05
- **Final completion:** 2026-05-31
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084053, "A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05084053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*